nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.0726	0.284	CbGpPWpGaD
Plerixafor—CXCR4—adrenal cortex—hypothyroidism	0.0453	0.122	CbGeAlD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.0439	0.172	CbGpPWpGaD
Plerixafor—CXCR4—heart—hypothyroidism	0.0438	0.118	CbGeAlD
Plerixafor—CXCR4—cardiovascular system—hypothyroidism	0.0413	0.111	CbGeAlD
Plerixafor—CXCR4—pituitary gland—hypothyroidism	0.0366	0.0984	CbGeAlD
Plerixafor—CXCR4—adrenal gland—hypothyroidism	0.0327	0.0879	CbGeAlD
Plerixafor—CXCR4—blood—hypothyroidism	0.0327	0.0879	CbGeAlD
Plerixafor—CXCR4—thyroid gland—hypothyroidism	0.0315	0.0848	CbGeAlD
Plerixafor—CXCR4—female gonad—hypothyroidism	0.0305	0.0819	CbGeAlD
Plerixafor—CXCR4—testis—hypothyroidism	0.027	0.0727	CbGeAlD
Plerixafor—CXCR4—liver—hypothyroidism	0.0256	0.0687	CbGeAlD
Plerixafor—CXCR4—cerebellum—hypothyroidism	0.025	0.0671	CbGeAlD
Plerixafor—CXCR4—Peptide GPCRs—TSHR—hypothyroidism	0.0205	0.0803	CbGpPWpGaD
Plerixafor—Swelling—Liotrix—hypothyroidism	0.0127	0.0342	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0108	0.0424	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.0101	0.0395	CbGpPWpGaD
Plerixafor—Abdominal distension—Liotrix—hypothyroidism	0.00977	0.0262	CcSEcCtD
Plerixafor—Arthralgia—Dextrothyroxine—hypothyroidism	0.00783	0.021	CcSEcCtD
Plerixafor—Arthralgia—Levothyroxine—hypothyroidism	0.00783	0.021	CcSEcCtD
Plerixafor—Shock—Dextrothyroxine—hypothyroidism	0.00738	0.0198	CcSEcCtD
Plerixafor—Shock—Levothyroxine—hypothyroidism	0.00738	0.0198	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00727	0.0284	CbGpPWpGaD
Plerixafor—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00725	0.0195	CcSEcCtD
Plerixafor—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00725	0.0195	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00683	0.0184	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00683	0.0184	CcSEcCtD
Plerixafor—Insomnia—Dextrothyroxine—hypothyroidism	0.00678	0.0182	CcSEcCtD
Plerixafor—Insomnia—Levothyroxine—hypothyroidism	0.00678	0.0182	CcSEcCtD
Plerixafor—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00669	0.018	CcSEcCtD
Plerixafor—Dyspnoea—Levothyroxine—hypothyroidism	0.00669	0.018	CcSEcCtD
Plerixafor—Flatulence—Liotrix—hypothyroidism	0.00666	0.0179	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00648	0.0253	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00648	0.0253	CbGpPWpGaD
Plerixafor—Fatigue—Levothyroxine—hypothyroidism	0.00647	0.0174	CcSEcCtD
Plerixafor—Fatigue—Dextrothyroxine—hypothyroidism	0.00647	0.0174	CcSEcCtD
Plerixafor—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00618	0.0166	CcSEcCtD
Plerixafor—Feeling abnormal—Levothyroxine—hypothyroidism	0.00618	0.0166	CcSEcCtD
Plerixafor—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00613	0.0165	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00613	0.0165	CcSEcCtD
Plerixafor—Syncope—Liotrix—hypothyroidism	0.00606	0.0163	CcSEcCtD
Plerixafor—Urticaria—Dextrothyroxine—hypothyroidism	0.00596	0.016	CcSEcCtD
Plerixafor—Urticaria—Levothyroxine—hypothyroidism	0.00596	0.016	CcSEcCtD
Plerixafor—Loss of consciousness—Liotrix—hypothyroidism	0.00594	0.016	CcSEcCtD
Plerixafor—Abdominal pain—Levothyroxine—hypothyroidism	0.00593	0.0159	CcSEcCtD
Plerixafor—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00593	0.0159	CcSEcCtD
Plerixafor—Arthralgia—Liotrix—hypothyroidism	0.00576	0.0155	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00569	0.0223	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—TRH—hypothyroidism	0.00554	0.0216	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Liotrix—hypothyroidism	0.00552	0.0148	CcSEcCtD
Plerixafor—Shock—Liotrix—hypothyroidism	0.00543	0.0146	CcSEcCtD
Plerixafor—Asthenia—Levothyroxine—hypothyroidism	0.00538	0.0145	CcSEcCtD
Plerixafor—Asthenia—Dextrothyroxine—hypothyroidism	0.00538	0.0145	CcSEcCtD
Plerixafor—Hyperhidrosis—Liotrix—hypothyroidism	0.00533	0.0143	CcSEcCtD
Plerixafor—Pruritus—Levothyroxine—hypothyroidism	0.00531	0.0143	CcSEcCtD
Plerixafor—Pruritus—Dextrothyroxine—hypothyroidism	0.00531	0.0143	CcSEcCtD
Plerixafor—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00513	0.0138	CcSEcCtD
Plerixafor—Diarrhoea—Levothyroxine—hypothyroidism	0.00513	0.0138	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00503	0.0135	CcSEcCtD
Plerixafor—Insomnia—Liotrix—hypothyroidism	0.00499	0.0134	CcSEcCtD
Plerixafor—Paraesthesia—Liotrix—hypothyroidism	0.00495	0.0133	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—TSHB—hypothyroidism	0.00493	0.0193	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—TSHR—hypothyroidism	0.00493	0.0193	CbGpPWpGaD
Plerixafor—Dyspnoea—Liotrix—hypothyroidism	0.00492	0.0132	CcSEcCtD
Plerixafor—Vomiting—Dextrothyroxine—hypothyroidism	0.00477	0.0128	CcSEcCtD
Plerixafor—Vomiting—Levothyroxine—hypothyroidism	0.00477	0.0128	CcSEcCtD
Plerixafor—Fatigue—Liotrix—hypothyroidism	0.00476	0.0128	CcSEcCtD
Plerixafor—Rash—Dextrothyroxine—hypothyroidism	0.00473	0.0127	CcSEcCtD
Plerixafor—Rash—Levothyroxine—hypothyroidism	0.00473	0.0127	CcSEcCtD
Plerixafor—Dermatitis—Levothyroxine—hypothyroidism	0.00473	0.0127	CcSEcCtD
Plerixafor—Dermatitis—Dextrothyroxine—hypothyroidism	0.00473	0.0127	CcSEcCtD
Plerixafor—Constipation—Liotrix—hypothyroidism	0.00472	0.0127	CcSEcCtD
Plerixafor—Headache—Dextrothyroxine—hypothyroidism	0.0047	0.0126	CcSEcCtD
Plerixafor—Headache—Levothyroxine—hypothyroidism	0.0047	0.0126	CcSEcCtD
Plerixafor—Feeling abnormal—Liotrix—hypothyroidism	0.00455	0.0122	CcSEcCtD
Plerixafor—Gastrointestinal pain—Liotrix—hypothyroidism	0.00451	0.0121	CcSEcCtD
Plerixafor—Nausea—Dextrothyroxine—hypothyroidism	0.00446	0.012	CcSEcCtD
Plerixafor—Nausea—Levothyroxine—hypothyroidism	0.00446	0.012	CcSEcCtD
Plerixafor—Urticaria—Liotrix—hypothyroidism	0.00438	0.0118	CcSEcCtD
Plerixafor—Abdominal pain—Liotrix—hypothyroidism	0.00436	0.0117	CcSEcCtD
Plerixafor—Hypersensitivity—Liotrix—hypothyroidism	0.00407	0.0109	CcSEcCtD
Plerixafor—Asthenia—Liotrix—hypothyroidism	0.00396	0.0106	CcSEcCtD
Plerixafor—Pruritus—Liotrix—hypothyroidism	0.0039	0.0105	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00382	0.0149	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00378	0.0148	CbGpPWpGaD
Plerixafor—Diarrhoea—Liotrix—hypothyroidism	0.00378	0.0101	CcSEcCtD
Plerixafor—Dizziness—Liotrix—hypothyroidism	0.00365	0.0098	CcSEcCtD
Plerixafor—Vomiting—Liotrix—hypothyroidism	0.00351	0.00943	CcSEcCtD
Plerixafor—Rash—Liotrix—hypothyroidism	0.00348	0.00935	CcSEcCtD
Plerixafor—Dermatitis—Liotrix—hypothyroidism	0.00348	0.00934	CcSEcCtD
Plerixafor—Headache—Liotrix—hypothyroidism	0.00346	0.00929	CcSEcCtD
Plerixafor—Nausea—Liotrix—hypothyroidism	0.00328	0.00881	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—POMC—hypothyroidism	0.00319	0.0125	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TRH—hypothyroidism	0.00313	0.0122	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AVP—hypothyroidism	0.00291	0.0114	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TRH—hypothyroidism	0.00284	0.0111	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TSHB—hypothyroidism	0.00279	0.0109	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TSHR—hypothyroidism	0.00279	0.0109	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00254	0.00992	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TSHB—hypothyroidism	0.00253	0.0099	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TSHR—hypothyroidism	0.00253	0.0099	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CLTC—hypothyroidism	0.00194	0.00759	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—POMC—hypothyroidism	0.00193	0.00755	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—VAV3—hypothyroidism	0.00171	0.00667	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TRH—hypothyroidism	0.00168	0.00656	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AVP—hypothyroidism	0.00164	0.00642	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—VAV3—hypothyroidism	0.00155	0.00605	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TSHB—hypothyroidism	0.0015	0.00585	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TSHR—hypothyroidism	0.0015	0.00585	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AVP—hypothyroidism	0.00149	0.00583	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRL—hypothyroidism	0.00141	0.00552	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SH2B3—hypothyroidism	0.00133	0.00521	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—hypothyroidism	0.00109	0.00427	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—hypothyroidism	0.000992	0.00388	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRL—hypothyroidism	0.000989	0.00387	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VAV3—hypothyroidism	0.000915	0.00358	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AVP—hypothyroidism	0.000882	0.00345	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—hypothyroidism	0.000586	0.00229	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1—hypothyroidism	0.000563	0.0022	CbGpPWpGaD
